XenoTech to Use Waters Synapt HDMS System for Metabolomics Services | GenomeWeb

NEW YORK (GenomeWeb News) - Waters said today that XenoTech, a contract research organization based in Lenexa, Kan., has purchased a Waters Synapt High Definition Mass Spectrometry system.

XenoTech is using the system to provide metabolite profiling services, Waters said.

The CRO is using the Synapt, in combination with a Waters Acquity UltraPerformance Liquid Chromatograph, to provide its clients with in vitro drug metabolism study data.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.